NCT02135042 2026-04-03
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
Phase 2/3 Active not recruiting
Clinical Trials
3 trialsNCT05050162 2026-04-03
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
NRG Oncology
Phase 2/3 Suspended
NCT01769066 2016-02-23
Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC
Fudan University
Phase 2/3 Completed